---
title: "Creative Medical Tech surges 11% after hours on diabetes therapy patent approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295155351.md"
description: "Creative Medical Tech (CELZ) rose 11% in after-hours trading to $1.28, building on a 72% intraday jump after USPTO approved its exosome therapy patent."
datetime: "2026-08-06T23:22:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295155351.md)
  - [en](https://longbridge.com/en/news/295155351.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295155351.md)
---

# Creative Medical Tech surges 11% after hours on diabetes therapy patent approval

Creative Medical Tech Holdings Inc.(CELZ.US) 盘后涨超 11%，现报 1.28 美元。

该股在当日盘中交易时段曾大幅上涨**71.95%**。主要驱动因素为美国专利商标局（USPTO）批准了该公司针对 1 型糖尿病的外泌体免疫疗法专利。该专利保护其 MyeloCelz 平台，旨在利用干细胞编程的髓系细胞外泌体诱导免疫耐受并保护胰岛β细胞。

此外，Roth MKM 维持该股**买入**评级，并给出**20 美元**目标价。此前公司还宣布撤回 S-1 公开募股计划并达成**450 万美元**的认股权证行权协议，消除了稀释风险，提振了投资者信心。

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)

## Related News & Research

- [Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application](https://longbridge.com/en/news/295116081.md)
- [Creative Medical Technology Holdings issues mid-year update press release](https://longbridge.com/en/news/291420127.md)
- [Top 3 Real Estate Stocks That May Keep You Up At Night In August](https://longbridge.com/en/news/296231864.md)
- [Instagram Head of Product Design Explains Thinking Behind That New Logo and Responds to Critics: ‘It’s Important for Us to Embrace the Future’](https://longbridge.com/en/news/296134477.md)
- [LG Display Co., Ltd. $LPL Shares Sold by Renaissance Technologies LLC](https://longbridge.com/en/news/296076871.md)